RankAlpha logo
Back to Rankings

XERS

Xeris BiopharmaA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
XERS vs peer average
80/100
XERS vs. peer average (A vs. C)
Grade spread
A 1 · B 3 · C 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ABSI is the first available peer comparator.

Same-sector and similar-market-cap candidate, but no operating-comparability evidence supports using it as a valuation anchor.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerABSIAbsci
XERS
Xeris Biopharma
ABSI
Absci
Grade
A
F
Momentum
64
90
Value
61
41
Sentiment
100
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ABSI

XERS / ABSI
Grade Position
Above peers
XERS vs. peer average (A vs. C)
80/100
Momentum
64
ABSI
Value
61
XERS
Sentiment
100
XERS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XERS
1
ABSI
ABSI
F
20/100
+4
2
MAZE
MAZE
F
20/100
+4
3
TRAX
TRAX
N/A
-
-
4
TYRA
Tyra Biosciences Inc Common
B
80/100
+1
5
VIR
Vir Biotechnology Inc Common
C
60/100
+2
ABSI is the first peer returned for this comparison set.